PRECURSOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

Clinical trials for PRECURSOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new PRECURSOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA trials appear

Sign up with your email to follow new studies for PRECURSOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New cell therapy tested for Tough-to-Treat blood cancers

Disease control Ongoing

This early-stage study is testing the safety and best dose of a new cell therapy called FT819. It is for adults with B-cell cancers like lymphoma or leukemia that have come back or not responded to prior treatments. Researchers are giving FT819 alone or combined with another drug…

Matched conditions: PRECURSOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

Phase: PHASE1 • Sponsor: Fate Therapeutics • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

PRECURSOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

Get alerted when new PRECURSOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA trials appear

New cell therapy tested for Tough-to-Treat blood cancers